Generation of Recombinant Tool Antibodies to Support Cell and Gene Therapy Development

Highly specialized antibodies are required for cellular kinetics and bioanalytical assays supporting cell and gene therapy.

Watch this webinar to learn how antibody phage display combined with Bio-Rad’s new modular platform, based on SpyTag technology, enables the rapid construction of antibodies. These antibodies are available in multiple monovalent and bivalent formats with a variety of options for site-directed conjugation. Because these highly specific, well-characterized tool antibodies are sequence defined, a secure supply throughout the assay lifecycle is guaranteed. Antibodies are available in as little as nine weeks.